All In MedTech

Device Trial Radar · NCT02703662

Performance of Biologic Mesh Materials in Abdominal Wall Reconstruction

Performance of Biologic Mesh Materials in Abdominal Wall Reconstruction - A Randomized Controlled Trial

Last checked: Nov 20, 2026Latest source record: Feb 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

90

Planned (sponsor's estimate)

Start

Oct 26, 2017

Primary completion

Oct 2025

Study completion Dec 2025

Sponsor

Lead sponsor
University of CalgaryAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Medtronic
First posted
Mar 9, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To date, there have been no prospective randomized controlled trials that compare various biologic mesh materials in the context of abdominal wall reconstruction. As a result, this proposal describes a 'head to head' randomized controlled trial (RCT) between 2 of the market's most popular biologic meshes. Strattice (noncross-linked porcine dermis, LifeCell Inc.) will be compared to Permacol (cross-linked porcine dermis, Covidien Inc.) in a randomized manner. Although there are significant differences between these mesh products with regard to procurement, tissue processing and cost, clinical controlled trials are needed to compare their performance.

Conditions

  • Ventral Hernia

Interventions

  • Strattice biologic meshDevice

    Patients randomized to this group will be inserted one or more Strattice biologic meshes during the abdominal wall reconstruction surgical procedure.

  • Permacol biologic meshDevice

    Patients randomized to this group will be inserted one or more Permacol biologic meshes during the abdominal wall reconstruction surgical procedure.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The percentage of hernia recurrence in patients received the biologic meshes.Time frame: 12 months postoperation

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Foothills Medical Centre, Faculty of Medicine

    Calgary, Alberta, Canada · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.